Search Results - "Moore, Elena Diaz"

Three versus six cycles of adjuvant platinum-based chemotherapy in early stage clear cell ovarian carcinoma – A multi-institutional cohort by Prendergast, Emily N, Holzapfel, Marie, Mueller, Jennifer J, Leitao, Mario M, Gunderson, Camille C, Moore, Kathleen N, Erickson, Britt K, Leath, Charles A, Diaz Moore, Elena S, Cohen, Joshua G, Walsh, Christine S

“…Abstract Objectives To determine if 6 versus 3 cycles of adjuvant platinum-based chemotherapy with or without taxane impacts survival in early stage ovarian…”
Get full text

Venous Thromboembolism in Patients Receiving Extended Pharmacologic Prophylaxis After Robotic Surgery for Endometrial Cancer by Kim, Josephine S, Mills, Kathryn A, Fehniger, Julia, Liao, Chuanhong, Hurteau, Jean A, Kirschner, Carolyn V, Lee, Nita K, Rodriguez, Gustavo C, Yamada, S Diane, Diaz Moore, Elena S, Tenney, Meaghan E

“…This study aims to determine the rate of postoperative venous thromboembolism (VTE) in endometrial cancer patients undergoing robotic hysterectomy with or…”
Get more information

Clinical outcomes in ovarian cancer patients receiving three versus more cycles of chemotherapy after neoadjuvant treatment and interval cytoreductive surgery by Kim, Josephine S, Liang, Margaret I, Prendergast, Emily N, Alldredge, Jill, Datta, Avisek, Hurteau, Jean A, Kirschner, Carolyn V, Rodriguez, Gustavo, Vogel, Tilley J, Brooks, Rebecca A, Cass, Ilana, Cohen, Joshua G, Penner, Kristine R, Wang, Chi E, Diaz Moore, Elena S

“…To compare clinical outcomes for stage IIIC and IV ovarian cancer patients receiving neoadjuvant chemotherapy and interval cytoreductive surgery followed by up…”
Get more information

Direct Oral Anti-Coagulants Continue to Bud into Gynecological Cancer-Thrombosis Prevention by Tafur, Alfonso J., Moore, Elena Diaz

Get full text

Surviving and thriving: What do survivors of gynecologic cancer want? by Peerenboom, Rayne, Ackroyd, Sarah A., Chang, Cecilia, Moore, Elena Diaz, Vogel, Tilley Jenkins, Lippitt, Melissa H., Rodriguez, Gustavo, Kirschner, Carolyn V.

“…•Gynecologic cancer survivors’ top concern was fear of cancer recurrence.•Nutrition and weight loss were the most desired survivorship program…”
Get full text

P19 Incidence and implications of pseudoprogression in women with advanced or recurrent endometrial cancer on pembrolizumab/lenvatinib combination therapy by Ackroyd, Sarah, Knickerbocker, Abbey, Rodriguez, Gustavo, Lippitt, Melissa, Moore, Elena Diaz, Vogel, Tilley Jenkins

Get full text

Safety and efficacy of a four-step outpatient platinum desensitization protocol in women with gynecologic cancers who have had a platinum hypersensitivity reaction (2220) by Ackroyd, Sarah, Febbraro, Terri, Moore, Elena Diaz, Vogel, Tilley Jenkins, Lippitt, Melissa, Kirschner, Carolyn, Palafox, Anna, Rodriguez, Gustavo

Get full text

What do gynecologic cancer survivors desire in a survivorship program? by Ackroyd, Sarah, Lippitt, Melissa, Moore, Elena Diaz, Vogel, Tilley Jenkins, Rodriguez, Gustavo, Kirschner, Carolyn

“…This study aims to assess the concerns and quality of life (QOL) of women treated for gynecologic cancers who were invited to participate in a survivorship…”
Get full text

Tissue is the issue: Chemotherapy response score (CRS) is most predictive of response to neoadjuvant chemotherapy in advanced, high grade serous ovarian cancer (HGSOC) (488) by Knickerbocker, Abbey, Kuchta, Kristine, Donaldson, Carolyn, Moore, Elena Diaz, Lippitt, Melissa, Rodriguez, Gustavo, Watkin, William, Vogel, Tilley Jenkins

Get full text

P11 Tissue is the issue: chemotherapy response score (CRS) is most predictive of response to neoadjuvant chemotherapy in advanced, high grade serous ovarian cancer (HGSOC) by Knickerbocker, Abbey, Kuchta, Kristine, Donaldson, Carolyn, Moore, Elena Diaz, Lippitt, Melissa, Rodriguez, Gustavo, Watkin, William, Vogel, Tilley Jenkins

Get full text

Malignant bowel obstruction due to uterine or ovarian cancer: Are there differences in outcome? by Hoppenot, Claire, Peters, Pamela, Cowan, Matthew, Moore, Elena Diaz, Hurteau, Jean, Lee, Nita Karnik, Yamada, S. Diane

“…To describe and compare treatments and outcomes of patients with malignant bowel obstructions (MBO) due to uterine or ovarian cancer. Retrospective chart…”
Get full text